AIM: The significance of preoperative serum IL-6, TNFalpha and CRP levels in the progression of colorectal cancer (CRC) has not been fully elucidated. Our intention was to investigate their role and identify their prognostic significance. METHODS: The IL-6, TNFalpha and CRP levels were measured in 74 CRC patients and the relationships between their elevations and both the clinicopathological factors and prognosis of patients were investigated. Serum concentrations of human IL-6 and TNFalpha were determined by enzyme-linked immunosorbent assay (ELISA). CRP was measured by an immunoturbinometric method. RESULTS: Median IL-6, TNFalpha and CRP levels were significantly higher in CRC patients than in normal controls. High levels of serum IL-6, TNFalpha and CRP were correlated with larger tumor size. Furthermore, high IL-6 and high CRP levels were associated with reduced overall survival. CONCLUSION: Serum IL-6, TNFalpha and CRP levels definitely increase in CRC patients. Pre-operative serum elevation of IL-6 and CRP was thus found to be predictor of the prognosis of CRC patients. The clinical value of TNFalpha in CRC needs to be further investigated.
AIM: The significance of preoperative serum IL-6, TNFalpha and CRP levels in the progression of colorectal cancer (CRC) has not been fully elucidated. Our intention was to investigate their role and identify their prognostic significance. METHODS: The IL-6, TNFalpha and CRP levels were measured in 74 CRCpatients and the relationships between their elevations and both the clinicopathological factors and prognosis of patients were investigated. Serum concentrations of humanIL-6 and TNFalpha were determined by enzyme-linked immunosorbent assay (ELISA). CRP was measured by an immunoturbinometric method. RESULTS: Median IL-6, TNFalpha and CRP levels were significantly higher in CRCpatients than in normal controls. High levels of serum IL-6, TNFalpha and CRP were correlated with larger tumor size. Furthermore, high IL-6 and high CRP levels were associated with reduced overall survival. CONCLUSION: Serum IL-6, TNFalpha and CRP levels definitely increase in CRCpatients. Pre-operative serum elevation of IL-6 and CRP was thus found to be predictor of the prognosis of CRCpatients. The clinical value of TNFalpha in CRC needs to be further investigated.
Authors: Gennaro Galizia; Michele Orditura; Ciro Romano; Eva Lieto; Paolo Castellano; Luigi Pelosio; Vincenzo Imperatore; Giuseppe Catalano; Carlo Pignatelli; Ferdinando De Vita Journal: Clin Immunol Date: 2002-02 Impact factor: 3.969
Authors: Maria Gazouli; George Zavos; Ioannis Papaconstantinou; John C Lukas; Anastassios Zografidis; John Boletis; Alkiviadis Kostakis Journal: Anticancer Res Date: 2004 Mar-Apr Impact factor: 2.480
Authors: Anna Csiszár; Tamás Szentes; Bea Haraszti; Annamária Balázs; Gyôzô G Petrányi; Eva Pócsik Journal: Pathol Oncol Res Date: 2004-06-09 Impact factor: 2.874
Authors: Myfanwy H Hopkins; Joy Owen; Thomas Ahearn; Veronika Fedirko; W Dana Flanders; Dean P Jones; Roberd M Bostick Journal: Cancer Prev Res (Phila) Date: 2011-06-30
Authors: Alexander M Kulminski; Irina Culminskaya; Konstantin G Arbeev; Svetlana V Ukraintseva; Liubov Arbeeva; Anatoli I Yashin Journal: Rejuvenation Res Date: 2013-02 Impact factor: 4.663
Authors: Murat Bolayirli; Hande Turna; Timur Orhanoğlu; Resat Ozaras; Mahmut Ilhan; Mustafa Ozgüroğlu Journal: Med Oncol Date: 2007 Impact factor: 3.064
Authors: Kyung A Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Jin-Yeong Han; Kyeong Hee Kim; Ri Young Goh; Hong Jo Choi; Ki Jae Park; Mee Sook Roh; Hyo-Jin Kim; Hyuk-Chan Kwon; Jong Hoon Lee Journal: BMC Cancer Date: 2010-05-14 Impact factor: 4.430
Authors: Robert V Cooney; Weiwen Chai; Adrian A Franke; Lynne R Wilkens; Laurence N Kolonel; Loïc Le Marchand Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-05-15 Impact factor: 4.254